David S. McCullough
Chief Executive Officer at Enterin, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Zasloff | M | 78 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 8 years |
Denise Barbut | M | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 8 years |
George Abercrombie | M | 69 | 13 years | |
Nancy Hutson | M | 74 | 12 years | |
William P. Sheridan | M | 69 | 16 years | |
William Kinney | M | 66 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 8 years |
Richard D. Propper | M | 76 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 8 years |
Mark Finn | M | 81 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 7 years |
David Vogel | M | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 2 years |
Roger G. Mills | M | 67 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 3 years |
Ruediger Weseloh | M | - | 18 years | |
Jay Allen Brammer | M | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | - |
Donald Munoz | M | 56 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 3 years |
Elizabeth Cho-Fertikh | M | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Staab | M | 56 | 9 years | |
Michael A. Darwin | M | 62 | 8 years | |
Charlie Sanders | M | 91 | - | |
Karl-Ludwig Kley | M | 73 | 10 years | |
Friederike Rotsch | M | 51 | 18 years | |
Bernhard R. M. Ehmer | M | 69 | 20 years | |
Kenneth Lee | M | 76 | 12 years | |
Peder Jensen | M | 69 | 4 years | |
Stanley Erck | M | 76 | 10 years | |
Charles E. Bugg | M | 82 | 21 years | |
Michael Jones | M | 54 | 13 years | |
Matthew Emmens | M | 72 | 4 years | |
Robert S. Lowrey | M | 63 | 2 years | |
Albrecht Merck | M | 74 | 14 years | |
Thomas Lander | M | 71 | - | |
Wayne Paterson | M | 56 | 8 years | |
Robert C. Stoner | M | - | - | |
J. Michael Mills | M | 50 | 6 years | |
Inge Lues | M | - | - | |
Peter L. McCullough | M | 59 | - | |
Isabel de Paoli | F | 50 | 15 years | |
Heiner Pieper | M | - | - | |
Michel Cimon | M | - | 4 years | |
Jason Adair | M | - | 4 years | |
Christophe Couturier | M | 58 | 12 years | |
Thomas Kessler | M | 59 | - | |
Malte Peters | M | 61 | 1 years | |
Rajkumar Kannan | M | 61 | 9 years | |
K. Min | M | 57 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | - |
Julie VanOrsdel Daves | F | - | 4 years | |
Daniel L. Menichella | M | 64 | 5 years | |
Rolf Krebs | M | 84 | 8 years | |
Dorothea Wenzel | M | 55 | 17 years | |
Carl Gordon | M | 59 | 3 years | |
Beth Seidenberg | M | 67 | 6 years | |
David Smoller | M | 60 | 2 years | |
Jon Stonehouse | M | 63 | 4 years | |
Bernhard Scheuble | M | 71 | - | |
J. Claude Bennett | M | 90 | 12 years | |
Randolph Steer | M | 74 | 15 years | |
Randall B. Riggs | M | 57 | 2 years | |
Theo Siegert | M | 77 | 13 years | |
Irwin Scher | M | 84 | 3 years | |
Elliott T. Berger | M | 53 | 14 years | |
Lothar H. Finke | M | - | 9 years | |
Stephen Biggar | M | 53 | 6 years | |
Stuart R. Grant | M | 69 | 4 years | |
Elmar Schnee | M | 65 | 8 years | |
Achim Schäffler | M | - | 13 years | |
William W. Featheringill | M | 80 | 16 years | |
Marek Dziki | M | 61 | 1 years | |
Olaf Klinger | M | 59 | 4 years | |
Kostas Kaloulis | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 37 | 55.22% |
Germany | 30 | 44.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David S. McCullough
- Personal Network